A large real-world cohort study presented at 67th ASH Annual Meeting and Exposition examined whether adding low-dose aspirin to warfarin improves outcomes in patients with antiphospholipid syndrome and...
A new national analysis provides clinicians with evidence on how chronic obstructive pulmonary disease affects post-discharge outcomes in adults with sickle cell disease hospitalized for acute chest...
A new multicenter analysis presented at the 67th American Society of Hematology (ASH) Annual Meeting evaluates how often emergency departments meet national guidelines for timely opioid administration in...
A large contemporary U.S. electronic health record analysis highlights elevated risks of severe maternal morbidity and preterm birth among pregnant individuals with sickle cell disease, offering updated...
A new multicenter UK audit evaluated dapagliflozin use in adults with sickle cell disease–associated chronic kidney disease, offering clinicians early insight into safety, tolerability, and renal effects in...
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
Optimal management of multiple myeloma is evolving with the introduction of new and emerging therapeutic options. Ajay K. Nooka, MD, MPH, discusses these treatment options and updates to the standards of...
The researchers analyzed 569 patients with multiple myeloma, stratified patients on the basis of their percentage of CD56-expressing clonal MM cells, and then evaluated patient outcomes based on this...
